Printer Friendly

DU PONT MERCK NAMES ARNER ASSISTANT GENERAL COUNSEL

 DU PONT MERCK NAMES ARNER ASSISTANT GENERAL COUNSEL
 WILMINGTON, Del., Nov. 1 /PRNewswire/ -- The Du Pont Merck


Pharmaceutical Company has named Raymond G. Arner assistant general counsel-intellectual property.
 Arner, a resident of Jeffersonville, Pa., was previously an attorney with the Philadelphia law firm of Schnader, Harrison, Segal & Lewis. Prior to that he was manager of patent license coordination for Wyeth Laboratories in Radnor, Pa.
 The Philadelphia native graduated magna cum laude from Temple University School of Law. He also graduated magna cum laude from the Temple School of Pharmacy. Arner was a staff member of the Temple Law Review, a member of the Rho Chi national honor society for pharmacy and a member of the American, Pennsylvania and Philadelphia bar associations.
 Du Pont Merck, which began operations on Jan. 1, 1991, is an independent worldwide pharmaceutical company established by Du Pont (NYSE: DD) and Merck & Co., Inc. (NYSE: MRK). With R&D expenditures exceeding $230 million annually, it is a research-based company focused on therapeutics for cardiovascular and central nervous system diseases, oncology, inflammatory and viral diseases, and on radiopharmaceuticals. Du Pont Merck, headquartered in Wilmington, expects to report first-year sales of $700 million.
 /delval/
 -0- 11/1/91
 /CONTACT: Roger R. Morris of Du Pont Merck Pharmaceutical, 302-992-4747/
 (DD MRK) CO: Du Pont Merck Pharmaceutical Company ST: Delaware IN: MTC SU: PER LJ -- PH005 -- 0109 11/01/91 09:59 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 1, 1991
Words:232
Previous Article:RAYCOM AND ABC SPORTS JOIN FORCES TO CREATE 1991-92 BASKETBALL SCHEDULE
Next Article:MULTI-COLOR REPORTS SECOND QUARTER 1992 RESULTS
Topics:


Related Articles
DU PONT MERCK NAMES HORNER MANAGING DIRECTOR FOR U.K.
DU PONT MERCK CEO RECEIVES HONORARY DOCTORATE
DU PONT MERCK NAMES FLETCHER AS GOVERNMENT AFFAIRS MANAGER
DU PONT MERCK NAMES BLANK VP FOR WORLDWIDE MARKETING
DU PONT MERCK HONORS OUTSTANDING SALES ACHIEVEMENTS: DISTRICT OF THE YEAR AWARDS
ANTONIO J. GRILLO-LOPEZ JOINS IDEC PHARMACEUTICALS AS VICE PRESIDENT, MEDICAL AND REGULATORY AFFAIRS
ANTONIO J. GRILLO-LOPEZ JOINS IDEC PHARMACEUTICALS AS VICE PRESIDENT, MEDICAL AND REGULATORY AFFAIRS
DU PONT MERCK ANNOUNCES PERSONNEL APPOINTMENT
MEDCO RESEARCH NAMES DIRECTOR, RADIOPHARMACEUTICAL CLINICAL RESEARCH
DU PONT MERCK EXECUTIVE JOINS SYMPHONY PHARMACEUTICALS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters